Financial Management Professionals’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.53M | Buy |
6,071
+50
| +0.8% | +$10.8K | 0.14% | 54 |
|
|
2026
Q1 | $1.31M | Buy |
6,021
+470
| +8% | +$104K | 0.15% | 53 |
|
|
2025
Q4 | $1.27M | Sell |
5,551
-15
| -0.3% | -$3.42K | 0.13% | 58 |
|
|
2025
Q3 | $1.29M | Buy |
5,566
+11
| +0.2% | +$2.24K | 0.13% | 55 |
|
|
2025
Q2 | $1.03M | Sell |
5,555
-537
| -9% | -$99.8K | 0.12% | 62 |
|
|
2025
Q1 | $1.28M | Buy |
6,092
+576
| +10% | +$112K | 0.16% | 51 |
|
|
2024
Q4 | $980K | Buy |
5,516
+438
| +9% | +$80.5K | 0.12% | 65 |
|
|
2024
Q3 | $1M | Buy |
5,078
+87
| +2% | +$16.2K | 0.12% | 60 |
|
|
2024
Q2 | $856K | Buy |
4,991
+742
| +17% | +$123K | 0.12% | 63 |
|
|
2024
Q1 | $774K | Sell |
4,249
-875
| -17% | -$151K | 0.11% | 63 |
|
|
2023
Q4 | $794K | Buy |
5,124
+387
| +8% | +$56.4K | 0.13% | 54 |
|
|
2023
Q3 | $706K | Buy |
4,737
+478
| +11% | +$70.2K | 0.12% | 55 |
|
|
2023
Q2 | $574K | Buy |
4,259
+608
| +17% | +$89.2K | 0.1% | 67 |
|
|
2023
Q1 | $582K | Buy |
3,651
+330
| +10% | +$50.5K | 0.11% | 61 |
|
|
2022
Q4 | $537K | Buy |
3,321
+250
| +8% | +$38.3K | 0.11% | 57 |
|
|
2022
Q3 | $412K | Sell |
3,071
-916
| -23% | -$131K | 0.09% | 60 |
|
|
2022
Q2 | $611K | Sell |
3,987
-507
| -11% | -$77.5K | 0.15% | 50 |
|
|
2022
Q1 | $728K | Buy |
4,494
+224
| +5% | +$32.5K | 0.16% | 52 |
|
|
2021
Q4 | $578K | Buy |
4,270
+9
| +0.2% | +$1.06K | 0.12% | 56 |
|
|
2021
Q3 | $460K | Buy |
4,261
+293
| +7% | +$33.5K | 0.11% | 52 |
|
|
2021
Q2 | $447K | Buy |
3,968
+222
| +6% | +$25K | 0.12% | 51 |
|
|
2021
Q1 | $405K | Buy |
3,746
+434
| +13% | +$46.4K | 0.11% | 46 |
|
|
2020
Q4 | $355K | Buy |
3,312
+155
| +5% | +$14.9K | 0.1% | 48 |
|
|
2020
Q3 | $277K | Buy |
3,157
+80
| +3% | +$7.53K | 0.1% | 48 |
|
|
2020
Q2 | $302K | Buy |
3,077
+2,393
| +350% | +$211K | 0.1% | 41 |
|
|
2020
Q1 | $52K | Sell |
684
-50
| -7% | -$4.26K | 0.02% | 86 |
|
|
2019
Q4 | $65K | Buy |
734
+79
| +12% | +$6.56K | 0.02% | 87 |
|
|
2019
Q3 | $50K | Hold |
655
| – | – | 0.02% | 97 |
|
|
2019
Q2 | $48K | Hold |
655
| – | – | 0.02% | 100 |
|
|
2019
Q1 | $53K | Hold |
655
| – | – | 0.02% | 90 |
|
|
2018
Q4 | $60K | Hold |
655
| – | – | 0.04% | 72 |
|
|
2018
Q3 | $62K | Hold |
655
| – | – | 0.02% | 82 |
|
|
2018
Q2 | $61K | Sell |
655
-44
| -6% | -$4.3K | 0.02% | 81 |
|
|
2018
Q1 | $66K | Buy |
+699
| New | +$76.8K | 0.03% | 78 |
|
|
2017
Q3 | – | Sell |
-150
| Closed | -$10K | – | 234 |
|
|
2017
Q2 | $10K | Hold |
150
| – | – | ﹤0.01% | 152 |
|
|
2017
Q1 | $9K | Buy |
150
+145
| +2,900% | +$9.12K | ﹤0.01% | 175 |
|
|
2016
Q4 | $0 | Buy |
+5
| New | +$305 | ﹤0.01% | 270 |
|
|
2016
Q3 | – | Sell |
-218
| Closed | -$13K | – | 295 |
|
|
2016
Q2 | $13K | Buy |
+218
| New | +$13.3K | 0.01% | 176 |
|
Other funds holding ABBV
Financial Management Professionals's ABBV Position: Q2 2026 in Review
Financial Management Professionals increased its AbbVie (ABBV) stake by 0.83% in Q2 2026, buying an estimated $10.8K and bringing the position to 6,071 shares worth $1.53M. The position accounts for 0.14% of the portfolio, ranked #54.
Financial Management Professionals first reported a position in ABBV in Q2 2016 and has held it in 38 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Financial Management Professionals held 6,071 shares of AbbVie worth $1.53M as of Q2 2026.
- Financial Management Professionals bought 50 AbbVie shares in Q2 2026, an estimated $10.8K.
- AbbVie made up 0.14% of Financial Management Professionals's portfolio in Q2 2026, its #54 holding.
- Financial Management Professionals first reported a position in AbbVie in Q2 2016 and has held it in 38 quarters since.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Financial Management Professionals's 13F filing for Q2 2026, filed 9 Jul 2026.